Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Medicinova Inc (NQ: MNOV )

5.670 USD -0.050 (-0.87%)
Official Closing Price Updated: 4:00 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 177,100
Open 5.680
Bid (Size) 5.500 (5)
Ask (Size) 5.800 (2)
Prev. Close 5.720
Today's Range 5.570 - 5.760
52wk Range 2.790 - 13.25
Shares Outstanding 41,129,073
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
MediciNova Enters into US$20 Million Securities Purchase Agreement with a fund managed by 3D Investment Partners
From GlobeNewswire News Releases
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Treatment of Progressive MS
From GlobeNewswire News Releases

Performance

YTD
+7.59%
+7.59%
1 Month
-8.99%
-8.99%
3 Month
+5.39%
+5.39%
6 Month
-3.41%
-3.41%
1 Year
-18.65%
-18.65%

More News

Read More
MediciNova Added to the NASDAQ Biotechnology Index
From GlobeNewswire News Releases
MediciNova Announces Positive Optical Coherence Tomography Results from the SPRINT-MS Phase 2b Trial of MN-166 (ibudilast) in Progressive MS Published in Multiple Sclerosis Journal
From GlobeNewswire News Releases
MediciNova Announces Initiation of Master Virus Seed Stock Production for its Intranasal COVID-19 Vaccine using BC-PIV Vector Technology
From GlobeNewswire News Releases
MediciNova Announces Presentation of Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model at The Liver Meeting Digital Experience™ 2020
From GlobeNewswire News Releases
MediciNova, in Collaboration with the University of Sydney and the Australasian Gastro-Intestinal Trials Group, Announces Plans for a Multi-center, Phase 2b Study to Evaluate MN-166 (ibudilast) in Che
From GlobeNewswire News Releases
MediciNova Appoints Carolyn Beaver to its Board of Directors and as Audit Committee Chair
From GlobeNewswire News Releases
MediciNova Announces Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model to be Presented at The Liver Meeting Digital Experience™ 2020
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Thursday's After-Market Session
Tags MNOV STRM Market News
From Benzinga
Sum Up The Parts: IBB Could Be Worth $181
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.